MIM1 induces COLO829 melanoma cell death through mitochondrial membrane breakdown, GSH depletion, and DNA damage

MIM1, the Mcl-1 – specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells

(2018) Michalina Respondek et al.   TOXICOLOGY IN VITRO

Detection of adverse drug reactions: evaluation of an automatic data processing applied in oncology performed in the French Diagnosis Related Groups database

(2017) Alexandre Quillet et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French study

(2017) Luc Cabel et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Lomefloxacin Induces Oxidative Stress and Apoptosis in COLO829 Melanoma Cells

(2017) Artur Beberok et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells

(2017) Yuzu Zhao et al.   Cell Death & Disease

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

(2016) Claus Garbe et al.   EUROPEAN JOURNAL OF CANCER

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells

(2016) Nabanita Mukherjee et al.   Oncotarget

The BCL-2 protein family, BH3-mimetics and cancer therapy

(2015) A R D Delbridge et al.   CELL DEATH AND DIFFERENTIATION

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

(2015) A. N. Hata et al.   Cancer Discovery

Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy

(2014) Nethia Mohana-Kumaran et al.   Pigment Cell & Melanoma Research

Apoptosis and Molecular Targeting Therapy in Cancer

(2014) Mohamed Hassan et al.   Biomed Research International

Glutathione depletion in survival and apoptotic pathways

(2014) Milena De Nicola et al.   Frontiers in Pharmacology

Evaluation and critical assessment of putative MCL-1 inhibitors

(2013) S Varadarajan et al.   CELL DEATH AND DIFFERENTIATION

Molecular biology of normal melanocytes and melanoma cells

(2013) Bizhan Bandarchi et al.   JOURNAL OF CLINICAL PATHOLOGY

BH3 Mimetics: Status of the Field and New Developments

(2013) C. Billard   MOLECULAR CANCER THERAPEUTICS

OBATOCLAX and ABT-737 Induce ER Stress Responses in Human Melanoma Cells that Limit Induction of Apoptosis

(2013) David Wroblewski et al.   PLoS One

Glutathione and modulation of cell apoptosis

(2012) Magdalena L. Circu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The Secret of MIM: A Novel, MCL-1-Specific Small Molecule

(2012) Joshua A. Kritzer   CHEMISTRY & BIOLOGY

A Competitive Stapled Peptide Screen Identifies a Selective Small Molecule that Overcomes MCL-1-Dependent Leukemia Cell Survival

(2012) Nicole A. Cohen et al.   CHEMISTRY & BIOLOGY

Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1

(2012) Daniela Senft et al.   PLoS One

The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy

(2011) P N Kelly et al.   CELL DEATH AND DIFFERENTIATION

Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737

(2011) K. M. Lucas et al.   CLINICAL CANCER RESEARCH

Targeting Mcl-1 for the therapy of cancer

(2011) Bridget A Quinn et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

BH3-only proteins: Orchestrators of apoptosis

(2010) Aisha Shamas-Din et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

A new understanding in the epidemiology of melanoma

(2010) Esther Erdei et al.   Expert Review of Anticancer Therapy

Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis

(2009) K. Boisvert-Adamo et al.   MOLECULAR CANCER RESEARCH

Expression and Function of Bcl-2 Proteins in Melanoma

(2008) Jurgen Eberle et al.   CURRENT GENOMICS